Status:
RECRUITING
Evaluation of the SMART IBD App in Pediatric IBD
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Inflammatory Bowel Disease (IBD)
IBD (Inflammatory Bowel Disease)
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will co...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of IBD (Crohn's Disease, ulcerative colitis, or indeterminate colitis)
- Prescribed at least one daily or weekly medication for treatment of IBD
- \<86% adherence to prescribed medication
- Access to internet via Wi-Fi or data plan and access to smartphone
- English fluency for patient and caregiver
Exclusion
- Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review
- Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review
Key Trial Info
Start Date :
October 23 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07195123
Start Date
October 23 2025
End Date
August 31 2027
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229